As a result of our accelerated pace, we now have both — we now expect both annual production and capital a trend towards the higher end of the range is provided. Looking ahead to 2024, we expect to average annual production volumes of approximately 580 Bcfe. And as we discussed last quarter, we also expect total capital expenditures to fall beginning of 2024 through 2025 to around $500 million. We will provide the full 2024 guidance with our next quarterly update. To conclude, the sustainable business model that we have created is continuing to deliver value to our shareholders throughout the commodity cycle. Our focus for the remainder of 2023 will remain on safe and compliant execution to develop our extensive natural gas asset base, accelerating free cash flow growth from our New Technologies Business on consistent and clinical capital allocation to grow our long-term free cash flow per share, and most importantly, as always on ensuring all our decisions continue to reflect a long term owner mindset.
With that, I’ll turn it back over to Tyler for Q&A.
Tyler Lewis : Thanks, Alan. Operator if you can please open the call for questions at this time.
Q – Bert Donnes : Hi, good morning, guys. Thanks for taking my question. On the New Tech front, would you say the $75 million to $100 million ranges is kind of the low hanging fruit. I know you mentioned, there’s the potential for meaningfully higher free cash flow. Just wonder expand if that next leg up, requires government legislation or new partnerships or anything like that, or if the $75 million to $100 million can stair step quickly to that meaningfully higher free cash flow?
Ravi Srivastava: Hey, Bert. This is Ravi. So the $75 million to $100 million that we guided to we have a good line-of-sight on what we can accomplish next year. We’re not making, like government legislations and all those uncertainties into that guidance for next year. However, like, depending on how some of these things come out, there’s an opportunity to grow that beyond 2024. And as we talked about our Adams Fork project, their CCS opportunities, low feedstock sale opportunities, all that stuff is contingent on how that project progresses. So all that stuff adds to that meaningful growth opportunities in ’25 onwards, but next year, we have good line-of-sight on what we need to do to get to that $75 million to $100 number.
Bert Donnes : Okay. And then could you break out, maybe where you’ve, you’ve gotten so far, that $75 million to $100 million between — I think there’s three buckets that you kind of, you put that in and maybe the year-to-date range, whether or not that is you know which bucket that falls into and then just little small ones here. But does some of that have a macro pricing supply demand baked into it? Like if we saw a better environment for that, would that free cash flow range move? Or is the $75 million to $100 million more of a fixed outcome? Thanks.
Alan Shepard : Yeah, to your first question that’s primarily associated with the free cash flow as you’re kind of seeing generated being less two quarters, which is the environmental attributes. They make up the bulk of that expectation for next year. And, that’s the range we given there kind of includes some of the subjectivity to the pricing and those regulatory pathways that we already have line of sight on to Ravi’s points. So —
Ravi Srivastava: Right. I think some of that $75 million to $100 million is contemplated on where we see where the market is today. But just like any, if you’re in tune with, where some of these environmental attributes, pricing and all that stuff is, there is some level of fluctuation volatility in it. But we think that $75 million to $100 million is still achievable.
Bert Donnes : Got you. Thanks, guys.
Operator: The next question comes from Zach Parham with JPMorgan. Please go ahead.
